Recent studies have demonstrated that the traditional 7-day course of metronidazole at a dosage of 200 mg. three times a day is not the only schedule effective in trichomoniasis (McClean, 1971; Csonka, 1971; Woodcock, 1972) . It was decided to assess the efficacy of metronidazole 400 mg. four times a day for 2 days; this dosage would facilitate its administration with tetracycline 500 mg. four times a day, a schedule sometimes used as an alternative to penicillin in the treatment of gonorrhoea.
Patients were included in the trial whenever the diagnosis was made while the doctor conducting the trial was on duty. The only patients excluded were those who had already been treated for a trichomonal infection in the previous 3 months. The patients were asked to return in 1 week and again after 1 month for repeat tests; further visits were made at the discretion of the patient, but an interval of at least 3 months elapsed before the results for each patient were reviewed.
The criteria for diagnosis and assessment of cure, although satisfactory for routine clinical work, might be judged inadequate for a scientific study. It was therefore decided to establish a control group of patients by the same criteria, and to treat them with the standard course of metronidazole 200 mg. three times a day for 7 days. The use of a control group made the difficult task of distinguishing between treatment failure and re-infection of less importance, as the results were to be judged relatively rather than in terms of absolute success or failure. The controls were patients in whom the diagnosis was made when the doctor conducting the trial was not on duty.
Material
The preliminary data are shown in Tables I and II. 
Results
These are shown in Table IV. In the trial group, 75 returned for follow-up tests; after 4 weeks there had been eight recurrences (10-7 per cent. of those followed) and a further nine recurrences were revealed by later visits, bringing the total to seventeen (22-7 per cent. of those followed).
In the control group, 68 returned for follow-up tests; after 4 weeks there had been five recurrences (7-3 per cent. of those followed), and later visits revealed a further eight, bringing the total to thirteen (19a1 per cent. of those followed).
SERUM LEVELS OF METRONIDAZOLE Fig. 1 shows the serum levels from four volunteers 3 and 24 hours after the first dose, and 12 hours after the final dose. Serum levels from eight subjects who had a single blood sample taken 36 hours after group.bmj.com on August 14, 2017 -Published by http://sti.bmj.com/ Downloaded from starting treatment (see below) are also shown. Since most strains of Trichomonas are sensitive in vitro to levels of 0-25-0-125 stg./ml. (Jennison, Stenton, and Watt, 1961) , it can be seen that values considerably above the minimum trichomonicidal level were maintained for at least 54 hours. Comparison with the fall-off of mean levels after single doses of 2 g. metronidazole (Fig. 2) suggests that adequate levels might have persisted for another 24 hours; thus the 2-day course of treatment probably provides effective blood levels for 3 to 4 days. (6) = Six on 2 g. stat (TW"oodcock, 1972 ) (4) = Four on 400 mg. four times a day (Fig. 1) (2) = Two on 200 mg. three times a day (8 a.m. specimens) (Kane, McFadzean, Squires, King, and Nicol, 1961) (1) = One of the two above (12-hourly specimens) METRONIDAZOLE AND TETRACYCLINE Whilst the trial was being planned, Szanto (1971) suggested a possible antagonism between oxytetracycline and metronidazole. Four of the trial patients who were also taking tetracycline 500 mg. four times daily had blood specimens taken 36 hours after starting treatment. Their serum metronidazole levels are shown in Fig. 1, together with the results at 36 hours for four patients on metronidazole alone.
There was no significant difference in the values obtained.
A review of the case notes of 500 consecutive female patients previously treated with metronidazole for trichomoniasis revealed thirteen who had been taking tetracycline concurrently. Three did not return for follow-up; the remaining ten showed no failures. The original suggestion of antagonism was based on a single case of treatment failure and it seems likely that this was a chance occurrence.
Discussion
Since the introduction of metronidazole in 1959, the then recommended regimen has continued to prove so satisfactory in the treatment of trichomoniasis that there has been little impetus for its modification. However, the introduction of different dose schedules for other conditions such as gingivitis (Duckworth, Waterhouse, Britton, Nuki, Sheiham, Winter, and Blake, 1966) and amoebiasis (Powell, Macleod, Wilmot, and Elsdon-Dew, 1966; Powell, Wilmot, and E]sdon-Dew, 1967; Powell, 1969) has led to the recognition that there is nothing sacred about '200 mg. three times a day for 7 days'.
In the present trial the results obtained using a dosage of 400 mg. four times a day for 2 days were as good as those obtained by the traditional regime.
The 
